Cellectis saw the highest growth of 3.49% in patent filings and 1.79% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.28% and grants by 1.24%. GlobalData’s DataBook provides a comprehensive analysis of Cellectis’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Cellectis has been focused on protecting inventions in United States(US) with ten publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 38% filings and 21% grants. The United States(US), Denmark(DK), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Cellectis is filings its patents. Among the top granted patent authorities, Cellectis has 21% of its grants in United States(US), 21% in European Patent Office(EPO) and 16% in Portugal(PT).
Immatics could be the strongest competitor for Cellectis
Patents related to immuno-oncology and genetically modified organism (GMO) lead Cellectis's portfolio
Cellectis has the highest number of patents in immuno-oncology followed by, genetically modified organism (GMO) and genomics. For immuno-oncology, nearly 35% of patents were filed and 38% of patents were granted in Q2 2024.
Leukemia related patents lead Cellectis portfolio followed by lymphoma, and graft versus host disease (gvhd)
Cellectis has highest number of patents in leukemia followed by lymphoma, graft versus host disease (gvhd), acute lymphocytic leukemia (all, acute lymphoblastic leukemia), and cell therapy. For leukemia, nearly 21% of patents were filed and 25% of patents were granted in Q2 2024.
For comprehensive analysis of Cellectis's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
